Home › Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx
 

Keywords :   


Accelerate Development Of Cancer Immunotherapy (iOnc) Drugs With New PathHunter Checkpoint Assays From DiscoveRx

2016-02-03 03:52:40| drugdiscoveryonline News Articles

DiscoveRx Corporation, the leading supplier of innovative cell-based assays and services for drug discovery and development, announced today the expansion of its PathHunter cell-based assays portfolio with the release of PathHunter Checkpoint Assays

Tags: development cancer drugs accelerate

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.06Musk says Tesla investors voting yes for pay deal
13.06Atlantic Tropical Weather Outlook
13.06Eastern North Pacific Tropical Weather Outlook
13.06US widens Russia sanctions in banking crackdown
13.06Atlantic Tropical Weather Outlook
13.06Eastern North Pacific Tropical Weather Outlook
13.06'We are creating new crops five-times faster'
12.06Atlantic Tropical Weather Outlook
More »